RING - Rituximab for Lupus Nephritis With Remission as a Goal

Clinical trial NCT01673295 · UNKNOWN

Trial details

NCT number: NCT01673295
Sponsor: Frédéric A. Houssiau, MD, PhD
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Lupus Nephritis

Start date: 2014-11-01
Primary completion: 2015-11-01
Enrollment: 194

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.